Ramipril Capsule
Product Images NDC 51655-296

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 51655-296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 296 52)

Label for Ramipril Capsules, USP 5 mg, containing 30 capsules. The label indicates prescription use only and provides storage instructions at controlled room temperature. It lists the product NDC as 51655-296-52 and names Northwind Pharmaceuticals as the repackager of the capsules.*

FDA Label Image

Figure 1. Kaplan-meier Estimates Of The Composite Outcome Of Myocardial Infarction, Stroke, Or Death From Cardiovascular Causes In The Ramipril Group And The Placebo Group (Ramipril Fig1)

A line graph comparing the proportion of patients over days of follow-up between Ramipril and Placebo groups. The x-axis represents days of follow-up up to around 1600 days, and the y-axis shows the proportion of patients up to 0.20. The graph includes a significance marker (P=0.0001), illustrating statistical comparison between the two lines.*

FDA Label Image

Figure 2. The Beneficial Effect Of Treatment With Ramipril On The Composite Outcome Of Myocardial Infarction, Stroke, Or Death From Cardiovascular Causes Overall And In Various Subgroups (Ramipril Fig2)

A forest plot chart showing the relative risk of a composite outcome in patients treated with Ramipril compared to placebo. It categorizes patients by conditions such as cardiovascular disease, diabetes, age, sex, hypertension, coronary artery disease, myocardial infarction history, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. The plot displays the number of patients per category and their relative risk with 95% confidence intervals.*

FDA Label Image

Chemical Structure (Ramipril Str)

Chemical structure of the active ingredient Ramipril, depicted as a molecular diagram showing its characteristic ring and chain formations, including ester, amide, and carboxyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.